These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28942130)

  • 41. Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis.
    Needham BD; Trent MS
    Nat Rev Microbiol; 2013 Jul; 11(7):467-81. PubMed ID: 23748343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa.
    Ohto U; Fukase K; Miyake K; Satow Y
    Science; 2007 Jun; 316(5831):1632-4. PubMed ID: 17569869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Chemical structure and biosynthesis of lipopolysaccharide--important component of the cell envelope of Gram-negative bacteria].
    Kaszowska M
    Postepy Hig Med Dosw (Online); 2004; 58():333-42. PubMed ID: 15459551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results.
    Cluff CW
    Adv Exp Med Biol; 2010; 667():111-23. PubMed ID: 20665204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Generation and characterization of avian vitelline antibodies against lipopolysaccharide and lipid A. 2. Investigations of specificity of egg yolk antibodies (IgY) against endotoxin].
    Sasse M; Hlinak A
    Berl Munch Tierarztl Wochenschr; 1998 Apr; 111(4):127-33. PubMed ID: 9581346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection.
    Maldonado RF; Sá-Correia I; Valvano MA
    FEMS Microbiol Rev; 2016 Jul; 40(4):480-93. PubMed ID: 27075488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detoxifying Escherichia coli for endotoxin-free production of recombinant proteins.
    Mamat U; Wilke K; Bramhill D; Schromm AB; Lindner B; Kohl TA; Corchero JL; Villaverde A; Schaffer L; Head SR; Souvignier C; Meredith TC; Woodard RW
    Microb Cell Fact; 2015 Apr; 14():57. PubMed ID: 25890161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The antagonist activity of lipid IVa on the stimulation by lipid A of TNF-alpha production from canine blood mononuclear cells.
    Takasawa K; Kano R; Maruyama H; Hasegawa A; Kamata H
    Vet Immunol Immunopathol; 2011 Sep; 143(1-2):167-9. PubMed ID: 21782253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of new biosynthetic pathways: the lipid A story.
    Raetz CR; Guan Z; Ingram BO; Six DA; Song F; Wang X; Zhao J
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S103-8. PubMed ID: 18974037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemical Hybridization of Vizantin and Lipid A to Generate a Novel LPS Antagonist.
    Yamamoto H; Oda M; Kanno M; Tamashiro S; Tamura I; Yoneda T; Yamasaki N; Domon H; Nakano M; Takahashi H; Terao Y; Kasai Y; Imagawa H
    Chem Pharm Bull (Tokyo); 2016; 64(3):246-57. PubMed ID: 26725501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defensive remodeling: How bacterial surface properties and biofilm formation promote resistance to antimicrobial peptides.
    Nuri R; Shprung T; Shai Y
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3089-100. PubMed ID: 26051126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemical synthesis of Burkholderia Lipid A modified with glycosyl phosphodiester-linked 4-amino-4-deoxy-β-L-arabinose and its immunomodulatory potential.
    Hollaus R; Ittig S; Hofinger A; Haegman M; Beyaert R; Kosma P; Zamyatina A
    Chemistry; 2015 Mar; 21(10):4102-14. PubMed ID: 25630448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Priming, induction and modulation of plant defence responses by bacterial lipopolysaccharides.
    Newman MA; Dow JM; Molinaro A; Parrilli M
    J Endotoxin Res; 2007; 13(2):69-84. PubMed ID: 17621548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mast cells as critical effectors of host immune defense against Gram-negative bacteria.
    Matsuguchi T
    Curr Med Chem; 2012; 19(10):1432-42. PubMed ID: 22360480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The chemical structure of bacterial endotoxin in relation to bioactivity.
    Rietschel ET; Kirikae T; Schade FU; Ulmer AJ; Holst O; Brade H; Schmidt G; Mamat U; Grimmecke HD; Kusumoto S
    Immunobiology; 1993 Apr; 187(3-5):169-90. PubMed ID: 8330896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds.
    Heumann D; Lauener R; Ryffel B
    J Endotoxin Res; 2003; 9(6):381-4. PubMed ID: 14733725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The interaction of cationic antimicrobial peptides with vesicles containing synthetic glycolipids as models of the outer membrane of gram-negative bacteria.
    Gobbo M; Biondi L; Filira F; Rocchi R
    J Pept Sci; 2006 Feb; 12(2):132-9. PubMed ID: 16075468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tetraacylated lipid A and paclitaxel-selective activation of TLR4/MD-2 conferred through hydrophobic interactions.
    Resman N; Oblak A; Gioannini TL; Weiss JP; Jerala R
    J Immunol; 2014 Feb; 192(4):1887-95. PubMed ID: 24420921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycolipid biosurfactants: main properties and potential applications in agriculture and food industry.
    Mnif I; Ghribi D
    J Sci Food Agric; 2016 Oct; 96(13):4310-20. PubMed ID: 27098847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences in innate immune responses upon stimulation with gram-positive and gram-negative bacteria.
    Tietze K; Dalpke A; Morath S; Mutters R; Heeg K; Nonnenmacher C
    J Periodontal Res; 2006 Oct; 41(5):447-54. PubMed ID: 16953821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.